ABC: (Pfizer) expects to pull in $US26 billion ($33.6 billion) of income from its COVID-19 vaccine this year.

Albert Bourla, Pfizer's chief executive officer: Based on what we've seen, we believe that a durable demand for our COVID-19 vaccine – similar to that of the flu vaccines – is a likely outcome.

We want to be a long-term partner to health authorities around the world in their ongoing efforts to combat COVID-19.

ABC: The company said it hoped ... to produce up to 2.5 billion doses this year and 3 billion in 2022.

"Durable demand" - that's a nice way to say that 'our vaccines won't actually stop Covid - but that's good news coz it means we'll make an even bigger killing going forward'.